Translational Development Acquisition Corp.
NASDAQ:TDACShell Companies
-$0.01 today
- Market cap
- $267.99M
- Beta
- 0.01
- P/E (TTM)
- 29.8
- EPS (TTM)
- $0.36
Volume 0.47M
Average 0.10M
TDAC Total Liabilities
Everything the company owes to creditors and other parties.
Translational Development Acquisition Corp.NASDAQ: TDAC
Total Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total liabilities rises 8.5% from a year ago
Total liabilities stood at $6.9M at the end of Q1 FY2026, up 8.5% from a year earlier and up 4.8% from the prior quarter. Over 3 fiscal years it compounded at +142.9% a year.
Context
- Total liabilities amounted to 3.8% of total assets at the end of Q1 FY2026, up 0.2 pp from a year earlier.
- Total liabilities increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total liabilities keeps rising in the next quarterly balance sheet after a +8.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 6.58M USD
- Year-over-year change
- +5.3%
- 3-year CAGR
- +142.9%
| Period | Period end | Total Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 6.58M | +5.3% |
| FY2024 | 2024-12-31 | 6.25M | +1125.8% |
| FY2023 | 2023-12-31 | 509.68K | +11.0% |
| FY2022 | 2022-12-31 | 459.34K | — |
Total Liabilities vs competitors
How TDAC compares with its peers on the latest reported figures
- TDAC's Mar 2026 total liabilities of $6.9M is the 5th highest of the 7 companies compared; the peer median is $10.42M.
- Its year-over-year change of +8.5% is the 4th highest of 6, against a peer median of +17.1%.
- Total liabilities amounts to 3.8% of total assets for TDAC, versus a peer median of 5.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $20.04M | -90.2% | — | 9.6% | |
MACIMelar Acquisition Corp. I | Mar 2026 | $11.73M | +76.9% | — | 6.6% |
| Mar 2026 | $11.33M | +3015.7% | +3.8% | 4.7% | |
| Mar 2026 | $9.52M | +17.1% | -7.8% | 5.1% | |
| Mar 2026 | $6.9M | +8.5% | +142.9% | 3.8% | |
NTWONewbury Street II Acquisition Corp | Mar 2026 | $6.16M | +0.8% | — | 3.3% |
| Jun 2025 | $440.23K | — | — | 105.4% | |
| Peer median (excluding TDAC) | $10.42M | +17.1% | -2.0% | 5.9% | |
Competitors are the stored peer set for TDAC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Translational Development Acquisition Corp.
NASDAQ:TDAC
Intrinsic Alpha fair value
Locked
Current Price
$10.88
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.